Browse diseases

…tudy, performed between September 2022 - January 2026, eligible PWH were stratified into low, intermediate, or high VF risk as desc…

…a probability of 3.1% at 1 year (95%CI 0.45–20.2, figure 1B).17 PWH discontinued B/F/TAF during follow-up. The cumulative probabili…

…ful and operationally actionable adherence benchmark in routine HIV care.Abstract P45 Figure 1ART forgiveness - virological outcome…

…t participants in BIC were younger (p=0.005) with higher zenith HIV-RNA (p=0.048) and higher CD4 cell counts (p=0.002) ( table 1). At 4…

…ntramuscular antiretroviral regimen approved for maintenance of HIV-1 virological suppression. Real-world data on durability and reas…

…d through multivariable Cox regressions.Results We included 615 PWH ( table 1). Overall, 39 VF occurred during a median follow-up o…

…continuation for any cause, TD, or virological failure, VF50, 2 HIV-RNA >50 cp/ml or a single >1000 cp/ml followed by ART change), acco…

…parallel sensitivity analyses using CVF-50.Results Overall, 490 PWH were included: 398 (81.2%) were males, with a median age of 52 …

… antigen, CMV-DNA and CSF studies were negative, except for CSF HIV-RNA (46 copies/mL). After exclusion of opportunistic diseases, cART…

…Cox regression to explore predictors of VF.Results Overall, 439 PWH were included: 314 (71.5%) were males, with a median age of 51 …

…between the centres. These findings highlight the resilience of HIV care systems in Italy and the importance of maintaining tireles…

…0.97-1.35) (tables 2-3).Conclusions In virologically suppressed PWH, no evidence for a difference in treatment failure was observed…